Trying to eliminate lymphatic filariasis, or “big foot,” from a country is like trying to permanently rid your garden of invasive plants and weeds.
February 28, 2017
After six years, during which over 429 million treatments were administered to over 202 million people, many of the six END in Africa-supported countries are ‘walking the final mile’ in the fight against several neglected tropical diseases (NTDs)—namely elephantiasis and trachoma—with plans to stop nationwide mass drug administration (MDA) for these two diseases by 2020.
February 1, 2017
Neglected tropical disease programs (NTDPs) have made significant achievements in the last decade. With the financial support of international donors, many affected countries that previously had disease cases nationwide, have transitioned to just experiencing disease “hot spots,” in which certain NTDs are largely confined to specific geographic areas within the country. A few countries have
- RT @Michelle4NTDs: More details about the Global Partners Meeting for NTDs. Let's #beatNTDs! https://t.co/TTHZG3gTNh
- Dr. Ameyo Dorkenoo has helped an entire country #BeatNTDs in Togo. #IWD2017 #NTDs @fhi360 @MectizanMDP https://t.co/MOuiJ83B9M
- Thank you to all women helping to #BeatNTDs, like these Nepalese women. #NoMoreNTDs #NTDs #IWD2017 https://t.co/c0vsft45TZ
Through the work of its END in Africa and END in Asia programs, FHI 360 is advancing USAID's goal of contributing to the global elimination of NTD by reducing prevalence of seven diseases—lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), schistosomiasis (snail fever), trachoma (blinding eye infection) and three soil-transmitted helminths (hookworm, roundworm, and whipworm).